Rabies is a zoonotic disease caused by the Lyssavirus rabies virus
(RABV) that can infect most mammals, including humans, where it has a case-fatality rate
of almost 100%. Although preventable by vaccination, rabies causes c. 59,000 human
fatalities every year worldwide. Thus, there exists an urgent need to establish an
effective therapy and/or improve dissemination of vaccines for humans and animals. These
outcomes require greater understanding of the mechanisms of RABV pathogenesis to identify
new molecular targets for the development of therapeutics and/or live vaccines with high
levels of safety. Importantly, a number of studies in recent years have indicated that
RABV specifically suppresses host immunity through diverse mechanisms and that this is a
key process in pathogenicity. Here, we review current understanding of immune modulation
by RABV, with an emphasis on its significance to pathogenicity and the potential
exploitation of this knowledge to develop new vaccines and antivirals.